Is OUTLOOK THERAPEUTICS Stock a Good Investment?
OUTLOOK THERAPEUTICS Investment Advice | OTLK |
- Examine OUTLOOK THERAPEUTICS's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research OUTLOOK THERAPEUTICS's leadership team and their track record. Good management can help OUTLOOK THERAPEUTICS navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact OUTLOOK THERAPEUTICS's business and its evolving consumer preferences.
- Compare OUTLOOK THERAPEUTICS's performance and market position to its competitors. Analyze how OUTLOOK THERAPEUTICS is positioned in terms of product offerings, innovation, and market share.
- Check if OUTLOOK THERAPEUTICS pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about OUTLOOK THERAPEUTICS's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in OUTLOOK THERAPEUTICS INC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if OUTLOOK THERAPEUTICS INC is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine OUTLOOK THERAPEUTICS Stock
Researching OUTLOOK THERAPEUTICS's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 36.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.06. OUTLOOK THERAPEUTICS INC last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 14th of March 2024.
To determine if OUTLOOK THERAPEUTICS is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding OUTLOOK THERAPEUTICS's research are outlined below:
| OUTLOOK THERAPEUTICS generated a negative expected return over the last 90 days | |
| OUTLOOK THERAPEUTICS has high historical volatility and very poor performance | |
| OUTLOOK THERAPEUTICS has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (75.37 T) with loss before overhead, payroll, taxes, and interest of (34.18 M). | |
| OUTLOOK THERAPEUTICS INC currently holds about 26.02 M in cash with (68.79 T) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 36.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Outlook Therapeutics Announces Complete Twelve Week Efficacy an |
OUTLOOK THERAPEUTICS Quarterly Accounts Payable |
|
OUTLOOK THERAPEUTICS uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in OUTLOOK THERAPEUTICS INC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to OUTLOOK THERAPEUTICS's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact OUTLOOK THERAPEUTICS's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises OUTLOOK THERAPEUTICS's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-14 | 2023-12-31 | -0.05 | -0.04 | 0.01 | 20 | ||
2023-12-22 | 2023-09-30 | -0.06 | -0.05 | 0.01 | 16 | ||
2022-12-29 | 2022-09-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2022-08-10 | 2022-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2021-05-14 | 2021-03-31 | -0.08 | -0.09 | -0.01 | 12 | ||
2022-02-14 | 2021-12-31 | -0.06 | -0.08 | -0.02 | 33 | ||
2020-05-15 | 2020-03-31 | -0.15 | -0.13 | 0.02 | 13 | ||
2023-08-14 | 2023-06-30 | -0.05 | -0.08 | -0.03 | 60 |
Know OUTLOOK THERAPEUTICS's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OUTLOOK THERAPEUTICS is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OUTLOOK THERAPEUTICS INC backward and forwards among themselves. OUTLOOK THERAPEUTICS's institutional investor refers to the entity that pools money to purchase OUTLOOK THERAPEUTICS's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Woodline Partners Lp | 2024-09-30 | 151.5 K | Northern Trust Corp | 2024-09-30 | 118.9 K | Federated Hermes Inc | 2024-09-30 | 91.4 K | Charles Schwab Investment Management Inc | 2024-09-30 | 51.5 K | Lvw Advisors, Llc | 2024-09-30 | 47.7 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 43.7 K | Susquehanna Fundamental Investments, Llc | 2024-06-30 | 41 K | Xtx Topco Ltd | 2024-09-30 | 37.3 K | Goldman Sachs Group Inc | 2024-09-30 | 35.6 K | Tang Capital Management Llc | 2024-09-30 | 1.6 M | Great Point Partners Llc | 2024-09-30 | 1.3 M |
OUTLOOK THERAPEUTICS's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.54 M.Market Cap |
|
OUTLOOK THERAPEUTICS's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.01) | (3.16) | |
| Return On Capital Employed | 6.01 | 6.31 | |
| Return On Assets | (3.01) | (3.16) | |
| Return On Equity | 1.19 | 1.25 |
Determining OUTLOOK THERAPEUTICS's profitability involves analyzing its financial statements and using various financial metrics to determine if OUTLOOK THERAPEUTICS is a good buy. For example, gross profit margin measures OUTLOOK THERAPEUTICS's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of OUTLOOK THERAPEUTICS's profitability and make more informed investment decisions.
Evaluate OUTLOOK THERAPEUTICS's management efficiency
OUTLOOK THERAPEUTICS INC has return on total asset (ROA) of (0.8369) % which means that it has lost $0.8369 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0365) %, meaning that it created substantial loss on money invested by shareholders. OUTLOOK THERAPEUTICS's management efficiency ratios could be used to measure how well OUTLOOK THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, OUTLOOK THERAPEUTICS's Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 1.25 this year, although the value of Return On Tangible Assets will most likely fall to (3.16). At this time, OUTLOOK THERAPEUTICS's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 34.8 T this year, although the value of Non Current Liabilities Other will most likely fall to about 52.5 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | -4.5 K | -4.3 K | |
| Tangible Book Value Per Share | -4.5 K | -4.3 K | |
| Enterprise Value | 60.7 M | 97.1 M |
The decision-making processes within OUTLOOK THERAPEUTICS are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 0.63 |
Basic technical analysis of OUTLOOK Stock
As of the 20th of January, OUTLOOK THERAPEUTICS holds the Risk Adjusted Performance of (0.03), market risk adjusted performance of 0.7206, and Coefficient Of Variation of (2,184). In connection with fundamental indicators, the technical analysis model allows you to check available technical drivers of OUTLOOK THERAPEUTICS, as well as the relationship between them.OUTLOOK THERAPEUTICS's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OUTLOOK THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on OUTLOOK THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OUTLOOK THERAPEUTICS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
OUTLOOK THERAPEUTICS's Outstanding Corporate Bonds
OUTLOOK THERAPEUTICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OUTLOOK THERAPEUTICS INC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OUTLOOK bonds can be classified according to their maturity, which is the date when OUTLOOK THERAPEUTICS INC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Understand OUTLOOK THERAPEUTICS's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing OUTLOOK THERAPEUTICS's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.7206 | |||
| Mean Deviation | 5.35 | |||
| Coefficient Of Variation | (2,184) | |||
| Standard Deviation | 10.12 | |||
| Variance | 102.32 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | 0.7106 | |||
| Maximum Drawdown | 72.39 | |||
| Value At Risk | (8.29) | |||
| Potential Upside | 11.84 | |||
| Skewness | (3.83) | |||
| Kurtosis | 26.0 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.7206 | |||
| Mean Deviation | 5.35 | |||
| Coefficient Of Variation | (2,184) | |||
| Standard Deviation | 10.12 | |||
| Variance | 102.32 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | 0.7106 | |||
| Maximum Drawdown | 72.39 | |||
| Value At Risk | (8.29) | |||
| Potential Upside | 11.84 | |||
| Skewness | (3.83) | |||
| Kurtosis | 26.0 |
Consider OUTLOOK THERAPEUTICS's intraday indicators
OUTLOOK THERAPEUTICS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OUTLOOK THERAPEUTICS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
OUTLOOK THERAPEUTICS Corporate Filings
8K | 16th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 3rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of June 2024 Other Reports | ViewVerify |
OUTLOOK Stock media impact
Far too much social signal, news, headlines, and media speculation about OUTLOOK THERAPEUTICS that are available to investors today. That information is available publicly through OUTLOOK media outlets and privately through word of mouth or via OUTLOOK internal channels. However, regardless of the origin, that massive amount of OUTLOOK data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OUTLOOK THERAPEUTICS news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OUTLOOK THERAPEUTICS relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OUTLOOK THERAPEUTICS's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OUTLOOK THERAPEUTICS alpha.
OUTLOOK THERAPEUTICS Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards OUTLOOK THERAPEUTICS can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
OUTLOOK THERAPEUTICS Corporate Management
| Terry Dagnon | Chief Officer | Profile | |
| Balu Balasubramanian | Advisor | Profile | |
| Jeffrey Evanson | Chief Officer | Profile | |
| Jedd Comiskey | Senior Europe | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.06) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between OUTLOOK THERAPEUTICS's value and its price, as these two are different measures arrived at by various means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.